Approvals/NMPA/Recombinant Human Papillomavirus 9-Valent (Types 6,11,16,18,31,33,45,52,58) Vaccine (Escherichia coli)

Approved

生物制品

Recombinant Human Papillomavirus 9-Valent (Types 6,11,16,18,31,33,45,52,58) Vaccine (Escherichia coli)

厦门万泰沧海生物技术有限公司🇨🇳 National Medical Products Administration

Approval Id: 8k4MCLCgebe
Approval Number: 国药准字S20250023
Generic Name: 九价人乳头瘤病毒疫苗(大肠埃希菌)
Generic Name En: Recombinant Human Papillomavirus 9-Valent (Types 6,11,16,18,31,33,45,52,58) Vaccine (Escherichia coli)
Trade Name: 馨可宁9（Cecolin 9）
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 每支0.5 mL，每1次人用剂量为0.5 mL（含重组HPV 6型L1蛋白30 μg，重组HPV 11型L1蛋白40 μg，重组HPV 16型L1蛋白60 μg，重组HPV 18型L1蛋白40 μg，重组HPV 31型L1蛋白20 μg，重组HPV 33型L1蛋白20 μg，重组HPV 45型L1蛋白20 μg，重组HPV 52型L1蛋白20 μg和重组HPV 58型L1蛋白20 μg）
Reg Date: 2025-05-27
Company Name: 厦门万泰沧海生物技术有限公司
Company Address: 福建省厦门市海沧区山边洪东路50号一层
Production Company Name: 厦门万泰沧海生物技术有限公司
Production Company Address: 福建省厦门市海沧区山边洪东路52号、60号
Company Detail Path: /organization/sha-men-mo-tai-cang-hai-sheng-wu-ji-zhu-you-xian-gong-si
Production Company Detail Path: /organization/sha-men-mo-tai-cang-hai-sheng-wu-ji-zhu-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

May 27, 2025

Approval ID

8k4MCLCgebe

Type

生物制品